New Gene Test Reduces Skin Reactions to Carbamazepine

A new gene variant test to guide treatment decisions led to reductions in the incidence of cutaneous adverse reactions to carbamazepine, a new study shows.
Medscape Medical News

https://ift.tt/2EjVmFj